FMP
Invitae Corporation
NVTA
NYSE
Inactive Equity
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
0.019 USD
-0.0105 (-55.26%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Kenneth D. Knight
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.invitae.comexchange
NYSE
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, Califor...
CIK
0001501134
ISIN
US46185L1035
CUSIP
46185L103
Address
1400 16th Street
Phone
415 374 7782
Country
US
Employee
1,700
IPO Date
Feb 12, 2015
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
NVTA Financial Summary
CIK
0001501134
Exchange
NYSE
Industry
Medical - Diagnostic...
Sector
Healthcare
CUSIP
46185L103
ISIN
US46185L1035
Country
US
Price
0.02
Beta
1.59
Volume Avg.
12.7M
Market Cap
5.44M
Shares
-
52-Week
0.015-2.34
DCF
6.97
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0
P/B
-
Website
https://www.invitae.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NVTA News
It looks like there's no news available.
